Biopartners Receives European Union Marketing Authorisation for its Biosimilar Recombinant Human Growth Hormone - Valtropin®
08-May-2006
Most read news
Topics
Organizations
Biopartners
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
FUJI PACKAGING GmbH - Hamburg, Germany
Go to page
Recipient's immune system governs stem cell regeneration - Controlling a stem cell transplant recipient’s immune response may be major key to successful bone regeneration
Go to page
Eden Biodesign and the University of Manchester Intellectual Property Limited develop cancer treatment
Go to page
Taprogge GmbH - Wetter (Ruhr), Germany
Go to page
PhosphonicS Ltd - Abingdon, United Kingdom
Go to page
Antisoma receives FDA approval for oral fludarabine, plans commercialisation deal to bring drug to US patients
Go to page
Biofocus Gesellschaft für biologische Anatytik mbH - Recklinghausen, Germany
Go to page
Wolfgang Krajewski GmbH & Co. - Lüneburg, Germany
Go to page
WIT Pharma - Moscow, Russian Federation
Go to page
Prometic and Top Meadows establish joint venture for development of Mad Cow Disease diagnostics
Go to page
Syntellix AG - Hannover, Germany
Go to page
F-Select GmbH - Planegg, Germany
Go to page